インデックス付き
  • Jゲートを開く
  • Genamics JournalSeek
  • ジャーナル目次
  • ウルリッヒの定期刊行物ディレクトリ
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • OCLC-WorldCat
  • パブロン
  • ジュネーブ医学教育研究財団
  • ユーロパブ
  • Google スカラー
このページをシェアする
ジャーナルチラシ
Flyer image

概要

STEAP4 Inactivation Correlates Poor Prognosis and might be a Possible Cause of steatotic Change in Hepatocellular Carcinoma, Detected by Triple-Combination Array Analysis

Fuminori Sonohara, Masamichi Hayashi, Mitsuhiro Hishida, Yoshikuni Inokawa, Mitsuro Kanda, Yoko Nishikawa, Shin Takeda, Hiroyuki Sugimoto, Tsutomu Fujii, Yasuhiro Kodera and Shuji Nomoto

In the present study, we originally designed triple-combination array analysis to identify tumor related genes in Hepatocellular Carcinoma (HCC). Using this method, the six transmembrane epithelial antigen of prostate family 4 (STEAP4), it was reported association with obesity and insulin-resistance, was detected as a candidate tumor suppressor gene. We found 32 of 48 (66.7%) tumor tissues showed STEAP4 promoter hypermethylation, and its expression level was significantly reduced in tumor tissues (p<0.0001). Methylated cases demonstrated significantly poorer recurrence-free survival (p=0.0462) and overall survival (p=0.0411). Triple-combination array analysis represents a useful technique for identifying novel tumor-related genes in HCC.